# An Observational Prospective Study to Understand the Usage Pattern of Ticagrelor With ACS (Acute Coronary Syndrome)

> **NCT02408224** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 3000 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02408224
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-27
- **Primary completion:** 2017-06-24
- **Final completion:** 2017-06-24
- **Target enrollment:** 3000 (ACTUAL)
- **Last updated:** 2018-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408224, "An Observational Prospective Study to Understand the Usage Pattern of Ticagrelor With ACS (Acute Coronary Syndrome)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02408224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*